List of Tables
Table 1. Global Biologics for Severe Asthma Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Biologics for Severe Asthma Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Biologics for Severe Asthma Market Competitive Situation by Manufacturers in 2025
Table 4. Global Biologics for Severe Asthma Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Biologics for Severe Asthma Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Biologics for Severe Asthma Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Biologics for Severe Asthma Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Biologics for Severe Asthma Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Biologics for Severe Asthma, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Biologics for Severe Asthma, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Biologics for Severe Asthma, Product Types and Applications
Table 12. Global Key Manufacturers of Biologics for Severe Asthma, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Biologics for Severe Asthma Companies by Tier (Tier 1, Tier 2, Tier 3), based on Biologics for Severe Asthma Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Biologics for Severe Asthma Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Biologics for Severe Asthma Sales by Region (K Units), 2021–2026
Table 18. Global Biologics for Severe Asthma Sales Market Share by Region (2021–2026)
Table 19. Global Biologics for Severe Asthma Sales by Region (K Units), 2027–2032
Table 20. Global Biologics for Severe Asthma Sales Market Share by Region (2027–2032)
Table 21. Global Biologics for Severe Asthma Revenue by Region (US$ Million), 2021–2026
Table 22. Global Biologics for Severe Asthma Revenue Market Share by Region (2021–2026)
Table 23. Global Biologics for Severe Asthma Revenue by Region (US$ Million), 2027–2032
Table 24. Global Biologics for Severe Asthma Revenue Market Share by Region (2027–2032)
Table 25. North America Biologics for Severe Asthma Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Biologics for Severe Asthma Sales by Country (K Units), 2021–2026
Table 27. North America Biologics for Severe Asthma Sales by Country (K Units), 2027–2032
Table 28. North America Biologics for Severe Asthma Revenue by Country (US$ Million), 2021–2026
Table 29. North America Biologics for Severe Asthma Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Biologics for Severe Asthma Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Biologics for Severe Asthma Sales by Country (K Units), 2021–2026
Table 32. Europe Biologics for Severe Asthma Sales by Country (K Units), 2027–2032
Table 33. Europe Biologics for Severe Asthma Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Biologics for Severe Asthma Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Biologics for Severe Asthma Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Biologics for Severe Asthma Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Biologics for Severe Asthma Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Biologics for Severe Asthma Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Biologics for Severe Asthma Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Biologics for Severe Asthma Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Biologics for Severe Asthma Sales by Country (K Units), 2021–2026
Table 42. Latin America Biologics for Severe Asthma Sales by Country (K Units), 2027–2032
Table 43. Latin America Biologics for Severe Asthma Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Biologics for Severe Asthma Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Biologics for Severe Asthma Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Biologics for Severe Asthma Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Biologics for Severe Asthma Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Biologics for Severe Asthma Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Biologics for Severe Asthma Revenue by Country (US$ Million), 2027–2032
Table 50. Global Biologics for Severe Asthma Sales (K Units) by Type (2021–2026)
Table 51. Global Biologics for Severe Asthma Sales (K Units) by Type (2027–2032)
Table 52. Global Biologics for Severe Asthma Sales Market Share by Type (2021–2026)
Table 53. Global Biologics for Severe Asthma Sales Market Share by Type (2027–2032)
Table 54. Global Biologics for Severe Asthma Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Biologics for Severe Asthma Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Biologics for Severe Asthma Revenue Market Share by Type (2021–2026)
Table 57. Global Biologics for Severe Asthma Revenue Market Share by Type (2027–2032)
Table 58. Global Biologics for Severe Asthma Price (US$/Unit) by Type (2021–2026)
Table 59. Global Biologics for Severe Asthma Price (US$/Unit) by Type (2027–2032)
Table 60. Global Biologics for Severe Asthma Sales (K Units) by Application (2021–2026)
Table 61. Global Biologics for Severe Asthma Sales (K Units) by Application (2027–2032)
Table 62. Global Biologics for Severe Asthma Sales Market Share by Application (2021–2026)
Table 63. Global Biologics for Severe Asthma Sales Market Share by Application (2027–2032)
Table 64. Global Biologics for Severe Asthma Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Biologics for Severe Asthma Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Biologics for Severe Asthma Revenue Market Share by Application (2021–2026)
Table 67. Global Biologics for Severe Asthma Revenue Market Share by Application (2027–2032)
Table 68. Global Biologics for Severe Asthma Price (US$/Unit) by Application (2021–2026)
Table 69. Global Biologics for Severe Asthma Price (US$/Unit) by Application (2027–2032)
Table 70. AstraZeneca Company Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Biologics for Severe Asthma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. AstraZeneca Biologics for Severe Asthma Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Amgen Company Information
Table 76. Amgen Description and Business Overview
Table 77. Amgen Biologics for Severe Asthma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Amgen Biologics for Severe Asthma Product
Table 79. Amgen Recent Developments/Updates
Table 80. Roche Company Information
Table 81. Roche Description and Business Overview
Table 82. Roche Biologics for Severe Asthma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Roche Biologics for Severe Asthma Product
Table 84. Roche Recent Developments/Updates
Table 85. Novartis Company Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Biologics for Severe Asthma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Novartis Biologics for Severe Asthma Product
Table 89. Novartis Recent Developments/Updates
Table 90. Sanofi Company Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Biologics for Severe Asthma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Sanofi Biologics for Severe Asthma Product
Table 94. Sanofi Recent Developments/Updates
Table 95. Regeneron Pharmaceuticals Company Information
Table 96. Regeneron Pharmaceuticals Description and Business Overview
Table 97. Regeneron Pharmaceuticals Biologics for Severe Asthma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Regeneron Pharmaceuticals Biologics for Severe Asthma Product
Table 99. Regeneron Pharmaceuticals Recent Developments/Updates
Table 100. GSK Company Information
Table 101. GSK Description and Business Overview
Table 102. GSK Biologics for Severe Asthma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. GSK Biologics for Severe Asthma Product
Table 104. GSK Recent Developments/Updates
Table 105. Teva Pharmaceuticals Company Information
Table 106. Teva Pharmaceuticals Description and Business Overview
Table 107. Teva Pharmaceuticals Biologics for Severe Asthma Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Teva Pharmaceuticals Biologics for Severe Asthma Product
Table 109. Teva Pharmaceuticals Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Biologics for Severe Asthma Distributors List
Table 113. Biologics for Severe Asthma Customers List
Table 114. Biologics for Severe Asthma Market Trends
Table 115. Biologics for Severe Asthma Market Drivers
Table 116. Biologics for Severe Asthma Market Challenges
Table 117. Biologics for Severe Asthma Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Biologics for Severe Asthma
Figure 2. Global Biologics for Severe Asthma Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Biologics for Severe Asthma Market Share by Type: 2025 & 2032
Figure 4. Omalizumab Product Picture
Figure 5. Benralizumab Product Picture
Figure 6. Dupirumab Product Picture
Figure 7. Mepolizumab Product Picture
Figure 8. Reslizumab Product Picture
Figure 9. Tezepelumab-ekko Product Picture
Figure 10. Global Biologics for Severe Asthma Market Value by Application (US$ Million), 2021–2032
Figure 11. Global Biologics for Severe Asthma Market Share by Application: 2025 & 2032
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Other
Figure 15. Global Biologics for Severe Asthma Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Biologics for Severe Asthma Market Size (US$ Million), 2021–2032
Figure 17. Global Biologics for Severe Asthma Sales (K Units), 2021–2032
Figure 18. Global Biologics for Severe Asthma Average Price (US$/Unit), 2021–2032
Figure 19. Biologics for Severe Asthma Report Years Considered
Figure 20. Biologics for Severe Asthma Sales Share by Manufacturers in 2025
Figure 21. Global Biologics for Severe Asthma Revenue Share by Manufacturers in 2025
Figure 22. Top 5 and Top 10 Global Biologics for Severe Asthma Players: Market Share by Revenue in Biologics for Severe Asthma in 2025
Figure 23. Biologics for Severe Asthma Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 24. Global Biologics for Severe Asthma Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 25. North America Biologics for Severe Asthma Sales Market Share by Country (2021–2032)
Figure 26. North America Biologics for Severe Asthma Revenue Market Share by Country (2021–2032)
Figure 27. United States Biologics for Severe Asthma Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. Canada Biologics for Severe Asthma Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Europe Biologics for Severe Asthma Sales Market Share by Country (2021–2032)
Figure 30. Europe Biologics for Severe Asthma Revenue Market Share by Country (2021–2032)
Figure 31. Germany Biologics for Severe Asthma Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. France Biologics for Severe Asthma Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. U.K. Biologics for Severe Asthma Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Italy Biologics for Severe Asthma Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Russia Biologics for Severe Asthma Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Asia Pacific Biologics for Severe Asthma Sales Market Share by Region (2021–2032)
Figure 37. Asia Pacific Biologics for Severe Asthma Revenue Market Share by Region (2021–2032)
Figure 38. China Biologics for Severe Asthma Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Japan Biologics for Severe Asthma Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. South Korea Biologics for Severe Asthma Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. India Biologics for Severe Asthma Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Australia Biologics for Severe Asthma Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. China Taiwan Biologics for Severe Asthma Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Southeast Asia Biologics for Severe Asthma Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Biologics for Severe Asthma Sales Market Share by Country (2021–2032)
Figure 46. Latin America Biologics for Severe Asthma Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Biologics for Severe Asthma Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Biologics for Severe Asthma Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Biologics for Severe Asthma Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Colombia Biologics for Severe Asthma Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Middle East and Africa Biologics for Severe Asthma Sales Market Share by Country (2021–2032)
Figure 52. Middle East and Africa Biologics for Severe Asthma Revenue Market Share by Country (2021–2032)
Figure 53. Turkey Biologics for Severe Asthma Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Saudi Arabia Biologics for Severe Asthma Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. UAE Biologics for Severe Asthma Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Global Sales Market Share of Biologics for Severe Asthma by Type (2021–2032)
Figure 57. Global Revenue Market Share of Biologics for Severe Asthma by Type (2021–2032)
Figure 58. Global Biologics for Severe Asthma Price (US$/Unit) by Type (2021–2032)
Figure 59. Global Sales Market Share of Biologics for Severe Asthma by Application (2021–2032)
Figure 60. Global Revenue Market Share of Biologics for Severe Asthma by Application (2021–2032)
Figure 61. Global Biologics for Severe Asthma Price (US$/Unit) by Application (2021–2032)
Figure 62. Biologics for Severe Asthma Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
